Sharp Avis: Intends to acquire Shanghai Qinli Industrial Co., Ltd. for 528 million yuan.

Shanghai Stock Exchange issued an inquiry letter on March 17, 2026, to Zhejiang Shapuaisi Pharmaceutical Co., Ltd., requesting the company to verify and supplement the disclosure of the reasonableness and fairness of the transaction valuation, the feasibility of performance commitments, the source of funds and payment ability, the ownership of the target assets, business qualifications, and transitional arrangements, etc.